ESCAPE-MeVO试验中再灌注治疗参与者的影像特征与临床结局
本事后分析纳入529例中等血管闭塞(MeVO)卒中患者,由中心盲法核心实验室评估基线CT、CTA和CT灌注影像特征。多变量分析显示,侧支循环状态是与90天mRS结局相关的影像变量(校正共同OR 0.82,95%CI 0.67-0.998)。
要点
- MeVO卒中患者中,CTA侧支状态是与90天mRS相关的影像变量。
- 侧支不良者EVT达到mRS 0-1概率25% vs 对照37%,侧支良好者47% vs 36%。
核心结论
- 在MeVO卒中患者中,CTA侧支状态与临床结局可能仅存在弱关联,需进一步研究。
研究设计与样本
- ESCAPE-MeVO随机试验的事后分析,纳入529例参与者(中位年龄75岁,IQR 64-82岁;284例男性)。
- 基线头部CT、CTA和CT灌注影像特征由中心盲法核心实验室评估,包括闭塞部位和侧支状态。
- 主要结局为90天改良Rankin量表(mRS)评分,采用logistic回归估计关联效应,并用乘法交互项检验IVT或EVT效应修正。
关键影像表现/征象
- 大多数MeVO位于大脑中动脉供血区(442/522,84.7%)。
- CTA侧支状态良好129/517例(25.0%),中等276例(53.4%),不良111例(21.5%)。
诊断标准与关键数值
- 侧支状态在多变量分析中与主要结局相关,校正共同OR为0.82(95%CI 0.67-0.998)。
临床应用与阅片要点
- 阅片时应常规评估MeVO患者的CTA侧支状态,因其可能与90天临床结局相关。
- 现有数据尚不支持仅凭侧支状态选择MeVO患者进行EVT,交互作用检验未达统计学意义。
局限性
- 本研究为随机试验的事后分析,影像亚组比较的统计效能有限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Background The randomized ESCAPE-MeVO trial revealed no benefit of endovascular thrombectomy (EVT) plus usual care in participants with acute stroke due to medium-vessel occlusion (MeVO), a heterogeneous patient population. Identifying subgroups most likely to benefit from EVT with the use of baseline imaging remains critical. Purpose To assess the associations of baseline imaging characteristics with clinical outcomes and intravenous thrombolysis (IVT) and EVT effects in participants with MeVO stroke. Materials and Methods In this post hoc analysis of the ESCAPE-MeVO trial (April 2022 to June 2024), head CT, CT angiography (CTA), and CT perfusion baseline imaging characteristics, including occlusion site and collateral status, were assessed in a central blinded core laboratory review. The primary outcome was the 90-day modified Rankin Scale (mRS) score. Outcomes stratified by imaging characteristics were compared between the EVT and control groups. Effect size estimates for associations of imaging features with outcomes were obtained using logistic regression. Multiplicative interaction terms determined whether imaging characteristics modified the effects of IVT or EVT on outcomes. Results A total of 529 ESCAPE-MeVO participants were included (median age, 75 years [IQR, 64-82 years]; 284 male). Most MeVOs (442 of 522 [84.7%]) were in the middle cerebral artery territory. Collateral status at CTA was good in 129 of 517 participants (25.0%), moderate in 276 (53.4%), and poor in 111 (21.5%). Collateral status was the imaging variable associated with the primary outcome in the multivariable analysis (adjusted common odds ratio, 0.82 [95% CI: 0.67, 0.998]). The probability of EVT achieving an adjusted mRS score of 0 or 1 was lower with EVT (25%) in participants with poor collaterals (vs 37% in the control arm) and higher in those with good collaterals (47% in the EVT arm vs 36% in the control arm), although the difference was not statistically significant (P[interaction] = .30). Conclusion Collateral status at CTA may have a weak association with clinical outcomes among patients with MeVO, warranting further investigation. Clinical trial registration no. NCT05151172 © RSNA, 2026 Supplemental material is available for this article. See also the editorial by Bilgin and Kallmes in this issue.
引用
- Ospel JM, Diprose WK, Uchida K, et al. Reperfusion Therapy in ESCAPE-MeVO Trial Participants: Imaging Characteristics and Clinical Outcomes. Radiology. 2026. PMID: 42188736. doi:10.1148/radiol.251769
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。